Otsuka Beijing Research Institute
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Subsidiary
- Established
- 2003-08-29
- Employees
- -
- Market Cap
- -
- Website
- http://www.obri.com.cn
Efficacy and Safety Study of Cilostazol to Prevent Reoccurrence of Stroke
Phase 3
Completed
- Conditions
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2006-03-16
- Lead Sponsor
- Otsuka Beijing Research Institute
- Target Recruit Count
- 720
- Registration Number
- NCT00202020
- Locations
- 🇨🇳
Huashan Hospital Shanghai Fudan University, Shanghai, China
🇨🇳2nd affiliated hospital, Zhejiang University, Hangzhou, Zhejiang, China
🇨🇳1st affiliated hospital, Guangzhou Zhongshan University, Guangzhou, Guangdong, China
Efficacy and Safety Study of Aripiprazole to Treat Schizophrenia
Phase 2
Completed
- Conditions
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2023-11-01
- Lead Sponsor
- Otsuka Beijing Research Institute
- Target Recruit Count
- 240
- Registration Number
- NCT00202007
- Locations
- 🇨🇳
Guangzhou Brain Hospital, Guangzhou, Guangdong, China
🇨🇳Psychiatry Dept. People's Hospital, Wuhan University, Wuhan, Hubei, China
🇨🇳Anding Hosp. Capital University of Medical Science, Beijing, China
© Copyright 2024. All Rights Reserved by MedPath